DK1242092T3 - Lægemiddelkombination til behandling af hovedpine omfattende mirtazapin og paracetamol eller et ikke-steroidt, antiinflammatorisk lægemiddel - Google Patents
Lægemiddelkombination til behandling af hovedpine omfattende mirtazapin og paracetamol eller et ikke-steroidt, antiinflammatorisk lægemiddelInfo
- Publication number
- DK1242092T3 DK1242092T3 DK01940311T DK01940311T DK1242092T3 DK 1242092 T3 DK1242092 T3 DK 1242092T3 DK 01940311 T DK01940311 T DK 01940311T DK 01940311 T DK01940311 T DK 01940311T DK 1242092 T3 DK1242092 T3 DK 1242092T3
- Authority
- DK
- Denmark
- Prior art keywords
- drug
- paracetamol
- treatment
- combination
- steroidal anti
- Prior art date
Links
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 title abstract 4
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 title abstract 4
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 title abstract 3
- 206010019233 Headaches Diseases 0.000 title abstract 3
- 231100000869 headache Toxicity 0.000 title abstract 3
- RONZAEMNMFQXRA-UHFFFAOYSA-N mirtazapine Chemical compound C1C2=CC=CN=C2N2CCN(C)CC2C2=CC=CC=C21 RONZAEMNMFQXRA-UHFFFAOYSA-N 0.000 title abstract 3
- 229960001785 mirtazapine Drugs 0.000 title abstract 3
- 229960005489 paracetamol Drugs 0.000 title abstract 3
- 239000000890 drug combination Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 abstract 3
- 239000003814 drug Substances 0.000 abstract 3
- 230000000694 effects Effects 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 239000012453 solvate Substances 0.000 abstract 2
- 239000003937 drug carrier Substances 0.000 abstract 1
- 230000002349 favourable effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP00201239 | 2000-04-05 | ||
| PCT/EP2001/004069 WO2001074340A2 (en) | 2000-04-05 | 2001-04-04 | Drug combination for the treatment of headache comprising mirtazapine and paracetamol or a non-steroidal anti-inflammatory drug |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1242092T3 true DK1242092T3 (da) | 2003-10-06 |
Family
ID=8171309
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK01940311T DK1242092T3 (da) | 2000-04-05 | 2001-04-04 | Lægemiddelkombination til behandling af hovedpine omfattende mirtazapin og paracetamol eller et ikke-steroidt, antiinflammatorisk lægemiddel |
Country Status (24)
| Country | Link |
|---|---|
| EP (1) | EP1242092B1 (da) |
| JP (1) | JP2004500410A (da) |
| KR (1) | KR20020086945A (da) |
| CN (1) | CN1537006A (da) |
| AT (1) | ATE244010T1 (da) |
| AU (2) | AU7393201A (da) |
| BR (1) | BR0109881A (da) |
| CA (1) | CA2404358A1 (da) |
| CZ (1) | CZ295982B6 (da) |
| DE (1) | DE60100431T2 (da) |
| DK (1) | DK1242092T3 (da) |
| ES (1) | ES2201039T3 (da) |
| HK (1) | HK1047547B (da) |
| HU (1) | HUP0300717A3 (da) |
| IL (1) | IL151815A0 (da) |
| MX (1) | MXPA02009811A (da) |
| NO (1) | NO20024684L (da) |
| NZ (1) | NZ521631A (da) |
| PL (1) | PL366237A1 (da) |
| PT (1) | PT1242092E (da) |
| RU (1) | RU2002129356A (da) |
| SK (1) | SK14162002A3 (da) |
| WO (1) | WO2001074340A2 (da) |
| ZA (1) | ZA200207701B (da) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200538100A (en) * | 2004-04-21 | 2005-12-01 | Akzo Nobel Nv | Mirtazapine salts |
| DE102004034043A1 (de) * | 2004-07-13 | 2006-02-09 | Krka Tovarna Zdravil, D.D. | Feste pharmazeutische Zusammensetzung, die Mirtazapin enthält |
| EP1792618A1 (en) * | 2005-11-30 | 2007-06-06 | Rainer Freynhagen | R-mirtazapine for the treatment of pain |
| WO2020229388A1 (en) * | 2019-05-12 | 2020-11-19 | Curatis Ag | Mirtazapine for use in medication overuse headache based on tension-type headache |
| KR102549596B1 (ko) | 2021-12-14 | 2023-07-03 | 재단법인 환동해산업연구원 | 생리활성을 가지는 사카이대마디말 추출물 및 그 제조방법 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1829539A3 (en) * | 1996-11-05 | 2008-02-20 | HEADEXPLORER ApS | A method for treating tension-type headache |
-
2001
- 2001-04-04 SK SK1416-2002A patent/SK14162002A3/sk unknown
- 2001-04-04 AT AT01940311T patent/ATE244010T1/de not_active IP Right Cessation
- 2001-04-04 BR BR0109881-0A patent/BR0109881A/pt not_active IP Right Cessation
- 2001-04-04 DE DE60100431T patent/DE60100431T2/de not_active Expired - Fee Related
- 2001-04-04 CA CA002404358A patent/CA2404358A1/en not_active Abandoned
- 2001-04-04 DK DK01940311T patent/DK1242092T3/da active
- 2001-04-04 HU HU0300717A patent/HUP0300717A3/hu unknown
- 2001-04-04 HK HK02109167.6A patent/HK1047547B/en not_active IP Right Cessation
- 2001-04-04 EP EP01940311A patent/EP1242092B1/en not_active Expired - Lifetime
- 2001-04-04 JP JP2001572085A patent/JP2004500410A/ja not_active Withdrawn
- 2001-04-04 CN CNA018075444A patent/CN1537006A/zh active Pending
- 2001-04-04 ES ES01940311T patent/ES2201039T3/es not_active Expired - Lifetime
- 2001-04-04 MX MXPA02009811A patent/MXPA02009811A/es active IP Right Grant
- 2001-04-04 RU RU2002129356/15A patent/RU2002129356A/ru not_active Application Discontinuation
- 2001-04-04 WO PCT/EP2001/004069 patent/WO2001074340A2/en not_active Ceased
- 2001-04-04 CZ CZ20023322A patent/CZ295982B6/cs not_active IP Right Cessation
- 2001-04-04 PL PL01366237A patent/PL366237A1/xx not_active Application Discontinuation
- 2001-04-04 KR KR1020027013286A patent/KR20020086945A/ko not_active Withdrawn
- 2001-04-04 PT PT01940311T patent/PT1242092E/pt unknown
- 2001-04-04 NZ NZ521631A patent/NZ521631A/en unknown
- 2001-04-04 AU AU7393201A patent/AU7393201A/xx active Pending
- 2001-04-04 IL IL15181501A patent/IL151815A0/xx unknown
- 2001-04-04 AU AU2001273932A patent/AU2001273932B2/en not_active Ceased
-
2002
- 2002-09-25 ZA ZA200207701A patent/ZA200207701B/en unknown
- 2002-09-30 NO NO20024684A patent/NO20024684L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NO20024684D0 (no) | 2002-09-30 |
| DE60100431D1 (de) | 2003-08-07 |
| NZ521631A (en) | 2005-01-28 |
| AU7393201A (en) | 2001-10-15 |
| HK1047547B (en) | 2003-10-10 |
| IL151815A0 (en) | 2003-04-10 |
| CA2404358A1 (en) | 2001-10-11 |
| AU2001273932B2 (en) | 2005-07-14 |
| DE60100431T2 (de) | 2004-05-19 |
| RU2002129356A (ru) | 2004-03-27 |
| HK1047547A1 (en) | 2003-02-28 |
| ATE244010T1 (de) | 2003-07-15 |
| KR20020086945A (ko) | 2002-11-20 |
| BR0109881A (pt) | 2003-06-03 |
| NO20024684L (no) | 2002-11-21 |
| ZA200207701B (en) | 2004-02-10 |
| MXPA02009811A (es) | 2003-05-27 |
| EP1242092B1 (en) | 2003-07-02 |
| HUP0300717A3 (en) | 2004-11-29 |
| PL366237A1 (en) | 2005-01-24 |
| ES2201039T3 (es) | 2004-03-16 |
| CZ20023322A3 (cs) | 2003-01-15 |
| WO2001074340A2 (en) | 2001-10-11 |
| WO2001074340A3 (en) | 2002-07-18 |
| PT1242092E (pt) | 2003-11-28 |
| CN1537006A (zh) | 2004-10-13 |
| SK14162002A3 (sk) | 2003-03-04 |
| HUP0300717A2 (hu) | 2003-07-28 |
| CZ295982B6 (cs) | 2005-12-14 |
| JP2004500410A (ja) | 2004-01-08 |
| EP1242092A2 (en) | 2002-09-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW200505484A (en) | Pharmaceutical compositions for hepatitis C viral protease inhibitors | |
| TW200716157A (en) | Pharmaceutical formulations and methods of treatment using the same | |
| ECSP055738A (es) | PROCESO ENANTIOSELECTIVO PARA LA PREPARACIÓN DE AMBOS ENANTIÓMEROS DE 10,11-DIHIDRO-10-HIDROXI-5H-DIBENZ-[b,f]-AZEPIN-5-CARBOXAMIDA Y SUS NUEVAS FORMAS DE CRISTAL | |
| MY143407A (en) | Indazole derivatives as inhibitors of hormone sensitive lipase | |
| NO20052888L (no) | Diamintriazoler anvendelige som inhibitorer av proteinkinaser | |
| ATE508735T1 (de) | Pulmonale verabreichung von aminoglykosiden | |
| ATE433973T1 (de) | Azolylaminoazine als inhibitoren von proteinkinasen | |
| NO20005224L (no) | BTK inhibitorer og fremgangsmåter for deres identifikasjon og anvendelse | |
| DK1525177T3 (da) | Substituerede 1,3-diphenylprop-2-en-1-on-derivater, fremstilling og anvendelse deraf | |
| DK1789419T3 (da) | Gyraseinhibitorer og anvendelser deraf | |
| NO20071742L (no) | Kinazoliner som er nyttige som modulatorer av ionekanaler | |
| AR024138A1 (es) | Inhibidores de la proliferacion celular | |
| DE60142913D1 (de) | Arzneilösungen enthaltend modafinilverbindungen | |
| DK1509492T3 (da) | Sedative hypnotiske midler med kort virkningsvarighed til anæstesi og sedation | |
| SE0003476D0 (sv) | Compounds | |
| WO2001052855A8 (en) | Drug combination for the treatment of depression and related disorders comprising mirtazapine and gepirone | |
| DK1406642T3 (da) | Fremgangsmåde til polyvalent bakteriofag-fremstilling til behandling af bakterielle infektioner | |
| DK1242092T3 (da) | Lægemiddelkombination til behandling af hovedpine omfattende mirtazapin og paracetamol eller et ikke-steroidt, antiinflammatorisk lægemiddel | |
| CY1109657T1 (el) | Φαρμακευτικες συνθεσεις ηρεμιστικου υπνωτικου μεσου ταχειας δρασης | |
| NO20031108L (no) | Farmasöytisk preparat for behandling av hodepine, og fremgangsmåte for fremstilling av preparatet | |
| EA200500175A1 (ru) | Соль морфин-6-глюкуронида | |
| ATE382363T1 (de) | Pharmazeutische zusammensetzung enthaltend bulbophyllum | |
| DK1146866T3 (da) | Metode til behandling af patienter med akne ved administration af cyclisk GMP PDE inhibitator | |
| AR035630A1 (es) | Metodo para tratar sintomas de migrana | |
| UY27563A1 (es) | 1,3-diarilprop-2-en-1-onas, composiciones que las contienen y su utilización. |